HAO — Haoxi Health Technology Cashflow Statement
0.000.00%
- $3.98m
- -$1.80m
- $48.52m
Annual cashflow statement for Haoxi Health Technology, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 20-F |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Net Income/Starting Line | 0.304 | 0.245 | 0.97 | 1.29 |
Depreciation | ||||
Non-Cash Items | 0.01 | — | — | — |
Unusual Items | ||||
Changes in Working Capital | 2.33 | -0.918 | -1.85 | -2.05 |
Change in Accounts Receivable | ||||
Change in Prepaid Expenses | ||||
Change in Other Assets | ||||
Change in Accounts Payable | ||||
Change in Accrued Expenses | ||||
Change in Taxes Payable | ||||
Change in Other Liabilities | ||||
Other Operating Cash Flow | ||||
Cash from Operating Activities | 2.65 | -0.671 | -0.872 | -0.748 |
Capital Expenditures | -0.003 | -0.009 | -0.045 | -0.055 |
Purchase of Fixed Assets | ||||
Other Investing Cash Flow Items | — | — | — | -3.07 |
Other Investing Cash Flow | ||||
Cash from Investing Activities | -0.003 | -0.009 | -0.045 | -3.13 |
Financing Cash Flow Items | -1.27 | 1.3 | -0.58 | 0 |
Other Financing Cash Flow | ||||
Net Issuance / Retirement of Stock | ||||
Net Issuance / Retirement of Debt | ||||
Cash from Financing Activities | -2.61 | 0.933 | 1.8 | 9.32 |
Foreign Exchange Effects | ||||
Beginning Cash Balance | ||||
Ending Cash Balance | ||||
Net Change in Cash | 0.036 | 0.238 | 0.91 | 5.45 |